OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
52
Results
Show all
Save search
Copy query
Show results for
Unknown
(50)
Transcriptomics
(2)
Organisms
Mus musculus
(1)
Homo sapiens
(1)
Repository
biostudies-arrayexpress
(2)
Publication Date
2016
(1)
2014
(1)
Study type
RNA-seq of coding RNA
(2)
Release Date
2021
(9)
2024
(6)
2022
(5)
2025
(4)
2017
(4)
2015
(4)
2014
(3)
2018
(3)
2016
(2)
2026
(2)
2023
(2)
2020
(2)
2013
(2)
2012
(2)
2019
(1)
2011
(1)
Previous
page
1 / 6
You're on page
1
page
2
page
3
page
4
page
5
page
6
Next
page
Sort
by:
Relevance
Page size
10
Phase III trial of carboplatin and paclitaxel with or without sorafenib in metastatic melanoma.
Not available
S-EPMC4878104
|
biostudies-literature
Cite
Imatinib for melanomas harboring mutationally activated or amplified KIT arising on mucosal, acral, and chronically sun-damaged skin.
Not available
S-EPMC4878082
|
biostudies-literature
Cite
SWOG S0221: a phase III trial comparing chemotherapy schedules in high-risk early-stage breast cancer.
Not available
S-EPMC4268253
|
biostudies-literature
Cite
Combined BRAF (Dabrafenib) and MEK inhibition (Trametinib) in patients with BRAFV600-mutant melanoma experiencing progression with single-agent BRAF inhibitor.
Not available
S-EPMC4226803
|
biostudies-literature
Cite
Phase III Randomized Study of 4 Weeks of High-Dose Interferon-α-2b in Stage T2bNO, T3a-bNO, T4a-bNO, and T1-4N1a-2a (microscopic) Melanoma: A Trial of the Eastern Cooperative Oncology Group-American College of Radiology Imaging Network Cancer Research Group (E1697).
Not available
S-EPMC5455684
|
biostudies-literature
Cite
Feasibility of Ultra-High-Throughput Functional Screening of Melanoma Biopsies for Discovery of Novel Cancer Drug Combinations.
Not available
S-EPMC5559310
|
biostudies-literature
Cite
Oligosaccharyltransferase inhibition induces senescence in RTK-driven tumor cells.
Not available
S-EPMC5393272
|
biostudies-literature
Cite
Correction: Landscape of Targeted Anti-Cancer Drug Synergies in Melanoma Identifies a Novel BRAF-VEGFR/PDGFR Combination Treatment.
Not available
S-EPMC11216593
|
biostudies-literature
Cite
Landscape of Targeted Anti-Cancer Drug Synergies in Melanoma Identifies a Novel BRAF-VEGFR/PDGFR Combination Treatment.
Not available
S-EPMC4604168
|
biostudies-literature
Cite
A first-in-human phase I, multicenter, open-label, dose-escalation study of the oral RAF/VEGFR-2 inhibitor (RAF265) in locally advanced or metastatic melanoma independent from BRAF mutation status.
Not available
S-EPMC5548886
|
biostudies-literature
Cite
Previous
page
1 / 6
You're on page
1
page
2
page
3
page
4
page
5
page
6
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets
